Stock Events

Stock Events

Outlook Therapeutics (41O.F) Q1 2026 Earnings

17FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.49

-0.34

-0.2

-0.05

Details

Expected EPS

-0.19122081454

Actual EPS

-0.18559640000000002

Surprise EPS

0.01

Surprise Percent

+2.94%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.18559640000000002 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.